In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

Search
AGORACOM News Flash

MARKET PRESSURE = BUYING OPPORTUNITIES

As predicted on the AGORACOM Blog, it appears we are now moving into capitulation phase and a great opportunity to buy good small-caps that have been thrown out with the bathwater. 

Follow AGORACOM commentary on:

  George's Blog    Grandich Blog

AGORACOM Micro-Blog

Close
AlphaRx > Message
Generic_profile

Re: NEWS - AlphaRx and Proprius Pharmaceuticals Achieve Enrollment Objective in Phase II Trial of Indaflex(TM) for Osteoarthritis of the Knee

Posted by: Tutty on December 11, 2006 04:44PM

In response to: NEWS - AlphaRx and Proprius... by AGORACOM

Well, guess we're delayed again. Won't hear about the results until sometime next year. First half of 2007
Did You Know?

AGORACOM members with a rank of Vice President or higher can update Company Profiles

Log in to Recommend Up_g

0 members recommend this.

Post a Reply

Please login to reply to this message.

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote